23andMe slumps after filing for bankruptcy protection

ReutersMar 24, 2025 9:02 AM

Shares of genetic testing firm 23andMe ME.O fall 42.5% to $1.03 premarket

On Sunday, ME filed for Chapter 11 bankruptcy protection to facilitate the sale of co

Co's CEO, Anne Wojcicki, has resigned after her attempts to buy out the company were rejected multiple times

Wojcicki plans to make another bid to buy the co during the bankruptcy process

Co has secured $35 mln in financing to continue operating during the sale process

Co's latest valuation is $50 mln, which is much lower than its $3.5 bln market value when it went public in 2021

Stock fell 79.5% in the last 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

What Are Crypto Stocks? Which Crypto Stocks Are the Best Investments?

As digital capital becomes increasingly enmeshed with global finance, the distinction between "traditional" and "crypto" stocks continues to blur. Whether you seek the aggressive growth of mining companies or the stability of blue-chip tech innovators, crypto stocks offer a flexible, accessible vehi

Musk’s XChat Is Coming to App Store, Meta, Apple and Finance World Are Trembling

Elon Musk’s XChat, the Western equivalent of WeChat, is set to launch on the App Store, issuing a direct challenge to giants such as Meta, Apple, and PayPal.

TSMC vs. Nvidia: Which AI Stock is a Better Investment?

TradingKey - Taiwan Semiconductor Manufacturing (TSMC) has established itself as a crucial player in the Artificial Intelligence (AI) supply chain and this has begun to manifest itself in the performance of TSMC’s shares.

Microsoft Launches Its Own AI Models and Ditches OpenAI Dependence - Is MSFT Stock a Buy at $370?

Microsoft at $370 is a 17%-revenue-growth, 47%-margin, $625-billion-backlog business trading at a multi-year low valuation, because the market is scared of macro noise. The AI model releases this week prove the moat is deepening, not narrowing.

Anthropic IPO 2026: What the Claude Mythos Release Delay Means for Investors and Stock Valuation

Anthropic has delayed the launch of its new AI model, Claude Mythos, projecting a responsible image but potentially weighing on its IPO process.

Featured Tools